CELL SEARCH SYSTEM
  3.III.i. RCB-CRL : Cell Lines Useful for General Purposes  
Cell No. Cell name General characteristics
  RCB0001     Vero     No interferon production, best for vaccine product. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0007     HeLa     Just like ATCC CCL 2, HeLa  
  RCB0008     V79     Chinese hamster lung fibroblast  
  RCB0016     CCRF-HSB-2     T cell leukemia  
  RCB0027     K562     Chronic myelogenous leukemia, sensitive to NK cell. Differentiate to erythroid cells .  
  RCB0035     WEHI-3     Secrete growth factors for hematpoietic stem cells  
  RCB0036     C127     Host for bovine papiloma virus  
  RCB0056     NIH3T3/14-1     Spontaneous transformant of NIH3T3  
  RCB0063     JTC-15     Subclone of AH-66, lost transplantability in rats.  
  RCB0065     JTC-27     Ascites hepatoma.  
  RCB0067     M     Capable to form collagen network  
  RCB0069     RLC-16     Epithelial cell from rat liver  
  RCB0070     RLC-18     Non tumorigenic in nude mice  
  RCB0072     RLC-27     Liver-derived cell, tumorigenic in nude mice  
  RCB0074     JTC-19     Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.  
  RCB0075     RCR-1     Astroglia cell line  
  RCB0076     LYM-1     Sticky cell from lymph node.  
  RCB0083     HLC-1     Lung adenocarcinoma  
  RCB0086     FM3A     Mammary carcinoma, grow in vitro and in vivo  
  RCB0096     Don(D-6)     Pseudodiploid, two marker chromosomes  
  RCB0097     CHL     Widely used in chromosome aberration test  
  RCB0098     A549     Lung carcinoma, refer to ATCC CCL185  
  RCB0102     IC-2     Mast cell precursor, respond to IL-3. Conditioned medium.  
  RCB0120     LT4Tr     Spontaneous transformant of LT4  
  RCB0135     L5178Y     Rapidly growing lymphoma  
  RCB0136     M10     Highly sensitive to X-ray irradiation  
  RCB0137     M10^(-)     Resistant to 6TG, isolated from M10  
  RCB0138     LX830     Highly sensitive to X-ray irradiation  
  RCB0142     Ehrlich     Ehrlich's ascite tumor  
  RCB0143     COS-1     SV40 large T antigen expressing, derived from CV-1. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0160     CV-1     Highly susceptible to SV40 infection. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0171     7T1     Contact inhibited, may transform spontaneously  
  RCB0174     SUSM-1     Transformed in vitro with carcinogen  
  RCB0180     MDBK     Kidney epithelial cell, equiv. to ATCC CRL6071  
  RCB0183     RK13     Susceptible to rubella virus, equiv. to ATCC CCL37  
  RCB0191     HeLa.S3     Most famous cultured human cell line  
  RCB0202     A431     High level of EGF receptor  
  RCB0205     BU25 TK-     Thymidine kinase defective HeLa  
  RCB0206     MOLT-4     T cell leukemia, the same patient as RCB1164 MOLT-3.  
  RCB0207     MRC-5 SV1 TG1     SV40-transformed, 6TG-resistant and HAT-sensitive.  
  RCB0208     LTK-     Thymidine kinase defective L cell  
  RCB0224     ST2     Bone marrow stroma cell-derived  
  RCB0243     Nil2C2     Highly metastatic sarcoma  
  RCB0244     Nil2C1     Highly metastatic sarcoma  
  RCB0245     Nil1C1     Highly metastatic sarcoma, synthesize hematoside  
  RCB0248     3T6     Non-contact inhibited  
  RCB0249     CKT-1     Very flat and thin kidney epithelial cell  
  RCB0251     VA-13     SV40-transformed WI-38.  
  RCB0256     BALL-1     Typical human B cell leukemia.  
  RCB0270     KG-1-C     Glioma, S-100 Protein producing. Cell growth is slow.  
  RCB0273     BRL     ES cell differentiation inhibitory activity (DIA)  
  RCB0282     NFSa Y83     In vivo transplantable highly metastatic sarcoma  
  RCB0283     C-1300     Highly metastatic neuroblastoma  
  RCB0284     Sq-1979     Metastatic epithelial cell  
  RCB0285     CHO-K1     Widely used cell line, especially for biotechnol  
  RCB0323     3Y1-SB-15     Tetraploid clone of 3Y1  
  RCB0324     3Y1-SB-16     Tetraploid clone of 3Y1  
  RCB0325     3Y1BU^(r-1)     Thymidine kinase-defective mutant of 3Y1  
  RCB0326     3Y1BU^(r-2)     Thymidine kinase-defective mutant of 3Y1  
  RCB0327     3Y1BU^(r-3)     Thymidine kinase-defective mutant of 3Y1  
  RCB0359     NG-3Y1-D303     3Y1 transformed with nitrosoguanidine  
  RCB0371     NG-3Y1-T18D     3Y1 transformed with nitrosoguanidine  
  RCB0403     CHO-K1 (SC)     CHO-K1 maintained in suspension culture.  
  RCB0411     HaP-T1     Mucin producing, BHP-induced pancreatic tumor  
  RCB0417     KU-1     Bovine B cell leukemia without virus production  
  RCB0418     KU-17     Bovine leukemia virus producing. Surface Ig (+). Application consideration  
  RCB0420     BHK-21C13-2P     Culturable in suspension, cf. ECACC ( BHK-21C13-3P).  
  RCB0423     BL312     Bovine derived lymphocyte.  
  RCB0426     SK-N-SH     Neuroblastoma, a target in CTL assay  
  RCB0428     Saos-2     Osteogenic sarcoma  
  RCB0431     T24     Bladder transitional-cell carcinoma  
  RCB0434     J774.1     Macrophage-like cell  
  RCB0435     U-937 DE-4     Cloned U-937, differentiate with TNF  
  RCB0439     LC-1F     Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.  
  RCB0440     LC-2/ad     Adenocarcinoma, moderately differentiated. Cell growth is slow. Application consideration  
  RCB0441     SCCKN     Highly sensitive to bleomycin  
  RCB0443     TC-YIK     Integrating HPV16, neurosecretory granules(+)  
  RCB0444     RERF-LC-AI     Japanese lung squamous carcinoma.  
  RCB0448     ARLJ301-3TR1     Spontaneous transformant of ARLJ301-3  
  RCB0452     HTC/C3     Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin  
  RCB0455     LC-1/sq     Lung Cancer-1/squamous. Parent cell line of RCB0438 LC-1/sq-SF, the same patient as RCB0439 LC-F. Cell growth is slow.  
  RCB0456     JTC-12     Cynomolgus monkey cell line. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0466     Lu-134-A     Small cell carcinoma, classic type. See Lu-134-B.  
  RCB0467     Lu-134-B     Small cell carcinoma, classic type. See Lu-134-A.  
  RCB0468     Lu-135     Small cell carcinoma, variant type. Application consideration  
  RCB0469     Lu-139     Small cell carcinoma, classic type  
  RCB0470     Lu-140     Small cell carcimoma, classic type. Application consideration  
  RCB0473     DD762     Mammary tumor cell line without C-type virus  
  RCB0474     K562/MTX-2     Methotrexate(MTX)-resistant K562 cell line  
  RCB0475     ILT-Mat     IL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).  
  RCB0476     Had-1     Newcastle disease virus resistant  
  RCB0477     NB9     Neuroblastoma ( Another name : CHP-212, PMID: 6871857 ) . N-myc gene amplification. Application consideration  
  RCB0478     NB16     Neuroblastoma. N-myc gene amplification.  
  RCB0480     NB69     Neuroblastoma. N-myc gene unamplified tumor. Cell growth is slow. Application consideration  
  RCB0481     TNB1     Neuroblastoma ( Another name : TGW, PMID: 2335222 ). N-myc gene amplification. Application consideration  
  RCB0482     MC-NB-1     Neuroblastoma. N-myc gene amplicon analysis. Application consideration  
  RCB0483     LA-N-1     Neuroblastoma. N-myc gene amplification.  
  RCB0484     LA-N-2     Neuroblastoma. N-myc gene amplification.  
  RCB0485     LA-N-5     Neuroblastoma. N-myc gene amplification.  
  RCB0486     CHP-126     Neuroblastoma. N-myc gene amplification. Cell growth is slow. Application consideration  
  RCB0487     CHP-134     Neuroblastoma. N-myc gene amplification. Application consideration  
  RCB0489     NEC8     Embryonal carcinoma, testis.  
  RCB0490     NEC14     Embryonal carcinoma, testis. Application consideration  
  RCB0494     NEC15     Embryonal carcinoma, testis. Application consideration  
  RCB0500     HGC-27     Gastric cancer undifferentiated, mucin producing  
  RCB0503     HeLa.S3(Mer^(-))     Repair deficient (mer~)  
  RCB0504     MR1-3     MNNG-reistant HeLa.S3(Mer~) cells  
  RCB0505     MR6     MNNG-resistant HeLa.S3(Mer~) cells  
  RCB0507     MR10-1     MNNG-resistant HeLa.S3(Mer~) cells  
  RCB0508     H-EMC-SS     Extraskeletal myxoid chondrosarcoma  
  RCB0510     ACL-15     Metastasis to liver, lung  
  RCB0511     RCN-9     Metastasis to liver, lung  
  RCB0512     RCN-H-4     Metastasis to liver  
  RCB0513     SKN     Estradiol-17 beta responsive leiomyosarcoma  
  RCB0515     HSKTC     Krukenberg tumor cell line  
  RCB0526     Jyg-MC(A)     murine mammary tumor cell lines. High level MMTV producer line.  
  RCB0527     Jyg-MC(B)     Murine mammary tumor cell lines. .Higher incidence in lung metastasis.  
  RCB0528     MtT/S     Estrogen-induced tumor. Growth hormone producing. Application consideration.  
  RCB0529     MtT/Se     Estradiol-dependent pituitary tumor. Application consideration.  
  RCB0530     MtT/SM     Growth hormone, prolactin producing. Application consideration.  
  RCB0531     TtT/M-87     Macrophage-like tumor dependent on L929 conditioned medium. Conditioned medium.  
  RCB0533     Y1     Buck-up culture of ECA85051002. Mouse steroid hormone secreting adrenal cortex cell line.  
  RCB0534     PK15     Buck-up culture of ECA86103005. Pig kidney, susceptible to hog cholea, foot & mouth disease.  
  RCB0535     RAW 264     Buck-up culture of ECA8510291 . Mouse leukemic monocyte. Abelson leukemia virus induced. Application consideration  
  RCB0536     STO     Tioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Back up culture of ECA85061804.  
  RCB0537     JM     Buck-up culture of ECA86010201. . Human T cell line with the ability to grow HIV, the same patient as Jurkat.  
  RCB0538     PU5-18     Mouse lymphoid tumor, macrophage like. Buck-up culture of ECA85051501 .  
  RCB0539     COS-7     SV40 large T antigen expressing, derived from CV-1. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0540     HAL-01     Acute lymphatic leukemia  
  RCB0544     MBT-2     Murine transitional cell carcinoma induced by FANFT  
  RCB0548     IA-5     Human large cell lung carcinoma. Taken from skin metastasis. In vivo-in vitro clonogenic assay.  
  RCB0554     IA-LM     Japanese lung large cell carcinoma  
  RCB0555     GCIY     Stomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.  
  RCB0557     B16 melanoma 4A5     Melanin pigment producing mouse melanoma. Application consideration  
  RCB0558     LLC     Highly metastatic and drug-resistant mouse tumor. Application consideration  
  RCB0559     K-1.fl     SFFV producing Friend leukemia cell line. Non-differentiating.  
  RCB0566     CGM1     EB transformed B cell line  
  RCB0637     CTLL-2     Cytotoxic T-cell line. IL-2 dependent.  
  RCB0638     TCS     Keratinizing cervix squamous carcinoma, CEA(+)  
  RCB0657     HOKUG     Glassy cell carcinoma. TA-4, CA125, neuron-specific enolase producing.  
  RCB0658     HHUA     Expressing receptor to estrogen and progesterone. Cell growth is slow.  
  RCB0659     HOUA-I     Poorly differentiated adenocarcinoma. Cell growth is slow.  
  RCB0660     HTMMT     Mixed Mullerian tumor.  
  RCB0662     HOTHC     Thyroid tumor. TAF, G-CSF, colloid producing.  
  RCB0665     HFWT     Wilms' tumor. CA125 and TPA producing.  
  RCB0666     HSNB     N-myc propagated. Neuron specific enolase producing.Application consideration  
  RCB0680     HKBMM     Human malignant meningioma.  
  RCB0687     KP-N-NS     Adrenal neuroblastoma derived from brain metastasis  
  RCB0688     QG-U     Japanese cervix carcinoma.  
  RCB0689     TCO-2     Derived from a single human as TCO-1. Said CEA, CA125, TPA (+).  
  RCB0700     HTMM     Malignant melanoma from lympho node.  
  RCB0715     CHAUT-G     Smooth muscle cell sarcoma from Chinese hamster.  
  RCB0725     MS-1     Small lung carcinoma. PTHrP producing.  
  RCB0733     NLS-6-5     Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.  
  RCB0735     OS-RC-2     Renal tumor cell from a Japanese. Transplantable to nude mice.  
  RCB0736     DJM-1     Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.  
  RCB0738     MTHC-1     Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.  
  RCB0739     MTHC-2     Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.  
  RCB0740     MTHC-3     Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.  
  RCB0748     Mm1     Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.  
  RCB0749     MFH-ino     Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.  
  RCB0753     OMC-1     Japanese cervix squamous cell carcinoma. Once said TA-4 positive.  
  RCB0755     OMC-3     Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+). Cell growth is slow.  
  RCB0760     MT-8     Rat fibrous histiocytoma. Acid phosphatase and nonspecific esterase are weakly positive.  
  RCB0761     505-05-01     Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.  
  RCB0762     MT-9     Rat fibrous histiocytoma. Acid phosphatase-, non-specific esterase- & monocytic antigen-positive.  
  RCB0763     GI-1     Human glioma separated from gliosarcoma.  
  RCB0764     Fvp^(r)B350     Topoisomerase II inhibitor VP-16 resistant FM3A mutant.  
  RCB0768     HP50-2     Hydrogen peroxide resistant HL60-derived clone.  
  RCB0769     HP100-1     Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.  
  RCB0774     EC-GI-10     Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.  
  RCB0777     HMV-II     Melanin producing. Originated from the same site of HMV-I.  
  RCB0778     CW-2     Colon carcinoma. CEA-positive, nude mouse-transplantable.  
  RCB0782     RC4     Normal rabbit cornea cells. Usually transform spontaneously during serial culture.  
  RCB0789     HSQ-89     Japanese maxillary simus squamous carcinoma  
  RCB0792     T88-M     IL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell  
  RCB0794     2C6     Initially insulin and glucagon producing, but not now. See RCB0795,0796,0797.  
  RCB0795     1B2C6     Human embryonic pancreas-derived cell line. See RCB0794,0796,0797.  
  RCB0796     1C3D3     Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.  
  RCB0797     1C3IKEI     Human embryonic pancreas-derived cell line. See RCB0794,0795,0796.  
  RCB0803     NBsusSR     Isolated from a patient with hiper dopaminemia andnorepinephrinemia.  
  RCB0805     Ba/F3     IL-3 dependent pro B cell line. Conditioned medium. Information.  
  RCB0806     Jurkat     Human T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.  
  RCB0808     MMAc     Human melanoma, spindle-shaped. Said DOPA (+). Cell growth is slow.  
  RCB0819     HMMME     Human malignant mesothelioma. CA19-9, CA125, and hyaluronic acid producing. Cell growth is slow.  
  RCB0820     HKBML     Human brain derived lymphoma. Epstein-Barr virus positive.  
  RCB0876     RGM1     So called clear cells from rat stomach mucosa.  
  RCB0881     OCUB-M     Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid.  
  RCB0882     OCUB-F     Same as OCUB-1, OCUB-M. Chromosome = pseudodiploid  
  RCB0966     HGRT     Benign mature tridermal teratoma.  
  RCB0967     HTST     Human sacrococcygeal teratoma.  
  RCB0978     HIRS-BM     Mixed mesodermal tumor consists of adenocarcinoma and rhabdomyosarcoma. Cell growth is slow.  
  RCB0980     Sa3     Squamous carcinoma cells derived from human oral cancer.  
  RCB0982     ECC4     Small-cell gastrointestinal carcinoma. High levels of creatine kinase brain isoenzyme. Cell growth is slow.  
  RCB0983     ECC10     Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.  
  RCB0988     CACO-2     Human colon carcinoma. Backup of ECA86010202 . Application consideration  
  RCB0989     COLO 679     Melanoma from a 47 year old female. Backup of ECA87061210 .  
  RCB0990     CPAE     Bovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Backup of ECA86111401 .  
  RCB0991     G-361     Human melanoma producing melanin up to 50 PDL. Backup of ECA88030401 .  
  RCB0992     HOS     Sensitive to further transformation with both virus and chemicals. Backup of ECA87070202 .  
  RCB0993     IEC 6     Rat small intestine epithelial cells. Backup of ECA88071401 .  
  RCB0994     MA104     Highly susceptible to Simian rotavirus SA11. Backup of ECA8510291 . Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB0995     MDCK     Canine kidney epithelial. Sensitive to wide range of viruses. Backup of ECA84121903 .  
  RCB0996     Mv.1.Lu(NBL-7)     Aleutian mink cells. Used for focus forming assays for murine and ferine sarcoma viruses.Back up culture of ECA88050503 .  
  RCB0999     MKN7     c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.  
  RCB1001     MKN45     Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.  
  RCB1002     MKN74     Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow.  
  RCB1003     MKN1     Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.  
  RCB1005     KP4     Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.  
  RCB1006     KP4-1     Pancreatic ductal cell carcinoma. PTHrP producing.  
  RCB1007     KP4-2     Pancreatic ductal cell carcinoma. PTHrP producing.  
  RCB1008     KP4-3     Pancreatic ductal cell carcinoma. PTHrP producing.  
  RCB1009     ECC12     Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. Application consideration  
  RCB1012     T3M-5     G-CSF producing thyroidal squamous carcinoma.  
  RCB1015     T3M-1 Clone2     G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM. Cell growth is slow.  
  RCB1017     T3M-1 Cl-10     G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.  
  RCB1018     T3M-3     Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone. Cell growth is slow.  
  RCB1020     T3M-10     Lung large cell carcinoma producing CSF. Cell growth is slow.  
  RCB1021     T3M-4     Pancreatic adenocarcinoma producing CEA. K-ras activated. Cell growth is slow.  
  RCB1022     T3M-11     Lung small cell carcinoma producing insulin-like growth factor II. Cell growth is slow.  
  RCB1024     IMR-90-SV     SV40 transformed human lung fibroblast.  
  RCB1025     RTH33     SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.  
  RCB1027     MEB4     Not expressing melanoma antigen. Control for GM-95 cell line.  
  RCB1032     NOS-1     Osteoid producing in vitro and in nude mice. Cell growth is slow.  
  RCB1033     NOS-2     Human osteosarcoma producing osteoid in vitro and in vivo(mouse). Cell growth is slow.  
  RCB1034     CJM     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1035     CJM Cl4     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1036     CJM Cl5     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1037     CJM Cl6     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1038     CJM Cl7     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1039     CJM Cl8     Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.  
  RCB1062     LMSU     Human cell line derived from lymph node metastasis of gastric cancer.  
  RCB1125     TOM-2     Glassy cell carcinoma from cervix. Cell growth is slow.  
  RCB1129     TGBC1TKB     Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration  
  RCB1130     TGBC2TKB     Japanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration  
  RCB1143     DA-1     IL-3 dependent mouse myeloid cells. MoLV induced.  
  RCB1144     DA-3     IL-3 dependent mouse myeloid cells. MoLV induced.  
  RCB1145     32D     IL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.  
  RCB1148     TGBC11TKB     Japanese gastric cancer, lymph node metastated. Application consideration  
  RCB1151     RCC10RGB     Kidney carcinoma from a Japanese patient. Cell growth is slow.  
  RCB1152     Sawano     Naturally raised CDDP(cisplatin)-resistant cell line.  
  RCB1154     KGN     Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.  
  RCB1164     MOLT-3     Human T cell leukemia, the same patient as RCB0206 MOLT-4.  
  RCB1165     YAC-1     Natural killer cell-sensitive mouse lymphoma.  
  RCB1166     KG-1     Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+  
  RCB1167     P-815     Mouse mastocytoma. Used as a target cells for cytotoxic T cell assays.  
  RCB1168     SKW-3     Human T cell leukemia (derivative of KE-37) . originally described to be established from the peripheral blood of a 61-year-old man with T cell chronic lymphocytic leukemia (CLL) in 1977; ; KE-37 was established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979  
  RCB1169     TGBC18TKB     Papillotubular adenocarcinoma of the Vater's papilla. Cell growth is slow. Application consideration  
  RCB1178     HuG1-PI     Stomach cancer, but producing hybrid type of alkaline phosphatase. See HuG1-N.  
  RCB1179     HuG1-N     Stomach cancer, but producing Nagao-type alkaline phosphatase. See HuG1-PI.  
  RCB1180     Tanoue     B-lineage acute lymphoblastic leukemia.  
  RCB1181     ST     A subclone of RCB1180 Tanoue.  
  RCB1184     Lu-165     Producing high level of anti-diuretic hormone.  
  RCB1185     TT1TKB     Rectal carcinoma from a Japanese patient. Cell growth is slow. Application consideration  
  RCB1186     TGBC14TKB     Japanese gallbladder tumor passed through a nude mouse. Application consideration  
  RCB1187     TUHR3TKB     Japanese kidney carcinoma cells. RCB original. Cell growth is slow.  
  RCB1191     5637     Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc.  
  RCB1192     MDA-MB-453     Human breast carcinoma established from an effusion. Application consideration  
  RCB1193     COLO-320     Described to produce serotonin, epinephrine.  
  RCB1196     TGBC24TKB     Japanese gallbladder carcinoma established from metastated ascite. Application consideration  
  RCB1198     TUHR4TKB     Japanese renal carcinoma cells. Cell growth is slow.  
  RCB1275     TUHR10TKB     Japanese renal carcinoma cells expressing HLA-A2402. Cell growth is slow.  
  RCB1278     MtT/E     Estrogen-induced pituitary tumor. Compared with MtT/S, MtT/SM, and MtT/Se. Application consideration.  
  RCB1279     TtT/GF     Pituitary folliculo-stellate-like cells. GFAP positive and S-100 positive.  
  RCB1280     TGBC50TKB     3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration  
  RCB1281     TGBC51TKB     3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration  
  RCB1282     TGBC52TKB     3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration  
  RCB1283     B16 melanoma     Mouse melanoma producing melanin. Application consideration  
  RCB1292     RBE     Human liver cholangiocarcinoma. Said CEA and CA19-9 producing.  
  RCB1293     SSP-25     Spindle cell-type cholangiocarcinoma cell line.  
  RCB1296     HNT-34     AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA. Application consideration  
  RCB1297     HYT-1     Human acute myeloid leukemia derived cell.  
  RCB1313     RERF-LC-KJ     Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.  
  RCB1316     CTB-1     Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.  
  RCB1317     KU-SN     Rare peripheral neuroectodermal tumor cells. Use collagen-coated dish.  
  RCB1366     HuH-7     Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.  
  RCB1367     HuH-6     Hepatoblastoma. Said albumin and alpha-fetoprotein producing.  
  RCB1369     NBT-T1     A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.  
  RCB1370     NBT-T2     A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.  
  RCB1371     NBT-L1     A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.  
  RCB1372     NBT-L2a     A subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.  
  RCB1373     NBT-L2b     A subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.  
  RCB1377     32Dcl3     Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.  
  RCB1378     MuSS     A-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.  
  RCB1383     TUHR14TKB     Japanese renal carcinoma cells. Cell growth is slow.  
  RCB1422     L929     TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.  
  RCB1423     BHK-21     The parent cell line used for the temperature sensitive cell line series of BN.  
  RCB1425     LCAM1     Human lung cancer derived cell.  
  RCB1426     PMF-ko14     Japanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.  
  RCB1429     SN-512     Japanese AML. Said i(12p)(p11) and unbalanced t(5;12). Need confirmation before use.  
  RCB1433     TEN     So called clear cell carcinoma. Said c-erb2(+), cathepsin D(+), CA125(+).  
  RCB1434     KE-39     Human cell line derived from gastric cancer  
  RCB1435     KE-97     Human cell line derived from intraperitoneal metastasis of gastric cancer  
  RCB1437     AW-EBV-LCL     B95-8 EB virus transformed leukemia cell line.  
  RCB1438     TW-EBV-LCL     B95-8 EB virus transformed (originally normal) B cell line.  
  RCB1440     ATN-1     Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).  
  RCB1450     LM8     A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).  
  RCB1451     L929     Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.  
  RCB1456     RCR-1     Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.  
  RCB1460     PCM6     Human myeloma cell.  
  RCB1461     JTC-15     Subclone of AH-66, lost transplantability in rats. Possible to culture in DMEM medium. See RCB0063.  
  RCB1464     DT40     Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.  
  RCB1472     M     Capable to form collagen network. Possible to culture in DMEM medium. See RCB0067.  
  RCB1473     LYM-1     Sticky cell from lymph node. Possible to culture in DMEM medium.  
  RCB1474     RLC-16     Epithelial cell from rat liver. Possible to culture in DMEM medium.  
  RCB1479     JTC-27     Ascites hepatoma. Possible to culture in DMEM medium. See RCB0065.  
  RCB1483     OV2944-HM-1     Lymphnode-metastatic ovarian tumor. So called HM-1 cells.  
  RCB1484     RLC-18     Non tumorigenic in nude mice. Possible to culture in DMEM medium.  
  RCB1485     JTC-12     Cynomolgus monkey cell line. Possible to culture in DMEM medium. See RCB0456. ワシントン条約対象。  
  RCB1486     JTC-19     Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .  
  RCB1487     MY-EBV-LCL     B95-8 EB virus transformed (originally normal) B cell line.  
  RCB1489     RLC-27     Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.  
  RCB1495     FU-RPNT-1     Scarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration  
  RCB1513     HOMM     Melanoma cells with melanin-granules. Cell growth is slow.  
  RCB1514     HOCE     Japanese choriocarcinoma cell line. Cell growth is slow. Application consideration  
  RCB1518     SS-A3-1     F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.  
  RCB1520     JHOC-5     Clear cell adenocarcinoma. Said CA125, CA72-4 producing. Application consideration  
  RCB1521     JHOS-2     Ovary serous adenocarcinoma. Said CA125, CA15-3 producing. Application consideration  
  RCB1525     HeLa.S3     = RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.  
  RCB1528     CCP-2     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  
  RCB1530     CCP-7     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  
  RCB1531     CCP-8     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.  
  RCB1534     MLC-1-B     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.  
  RCB1535     MLC-2-4     Bone marrow stroma cell line, depositing calcified matrix on the culture surface.  
  RCB1536     MLC-6     Osteoclast-like cell line derived from mouse (C3H/He). Cell growth is slow.  
  RCB1537     MLC-7     Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.  
  RCB1538     32Dcl3     Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.  
  RCB1539     P19.CL6     Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.  
  RCB1543     JHTKI-col-L     B lymphocytes isolated from a colon adenocarcinoma.  
  RCB1544     JHUAS-1     Uterine adenosquamous carcinoma. Said CEA and CA125 producing. Cell growth is slow. Application consideration  
  RCB1545     JHUAS-2-L     B lymphocyte isolated from Japanese adenosquamous carcinoma.  
  RCB1546     JHOS-3     Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow. Application consideration  
  RCB1547     JHUCS-1     Japanese uterine carcinosarcoma. Nude mouse transplantable. Application consideration  
  RCB1548     JHUEM-1     Japanese uterine endometrioid adenocarcinoma G2. Said CA125, CEA producing. Application consideration  
  RCB1549     YSCCC     Human cell line derived from cholangiocellular carcinoma. Cell growth is slow.  
  RCB1550     HL-60-R2     Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.  
  RCB1551     JHUEM-2     Japanese endometrioid adenocarcinoma. Application consideration  
  RCB1552     JHUEM-3     Human uterus endometrioid adenocarcinoma cell line. Application consideration  
  RCB1556     RF/6A 135     Spont. transformant from choroid retina. Only slightly reactive to Factor VIII. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1558     JHUS-nk1     Human uterus squamous cell carcinoma cell line. Application consideration  
  RCB1597     KKC     Mouse T cell line transformed by Gross leukemia virus.  
  RCB1598     NCKA     Mouse T cell line transformed by Gross leukemia virus.  
  RCB1600     KKF     Mouse T cell line transformed by Gross leukemia virus.  
  RCB1601     KKB     Mouse T cell line transformed by Gross leukemia virus.  
  RCB1604     DHA3-1     Mouse T cell hybridoma expressing double HA-tag alone.  
  RCB1605     DHA3-26     Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  
  RCB1606     DMyc3-45     Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .  
  RCB1607     DHA9-3     Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).  
  RCB1608     DHA9-13     Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).  
  RCB1609     DHA9-15     Mouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  
  RCB1610     DMyc9-36     Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.  
  RCB1635     K-562     Human CML derived cell line. Deposited directly from the institution that has established this cell.  
  RCB1637     293     Sheared human Ad5 DNA-transformed cell line. Widely used for production of manipulated adenovirus. Back up culture of ECA2737.  
  RCB1638     Hepa 1-6     Derived from BW7756 tumor in a C57L mouse. Back up culture of ECA3041.  
  RCB1639     LoVo     CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.  
  RCB1640     DAUDI     Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.  
  RCB1641     EL4     9,10-dimethyl-1,2benzanthracene induced lymphoma. Back up culture of ECA2504.  
  RCB1642     3T3 Swiss Albino     Contact inhibition. Buck up culture of ECA2854.  
  RCB1644     BeWo     It was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Back up culture of ECA2687.  
  RCB1645     Y79     Caucasian retinoblastoma. May have reverse transcriptase. Back up culture of ECA2583.  
  RCB1647     RAJI     Burkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles.  
  RCB1648     Hep G2     hepatocellular carcinoma. Produce alpha-fetoprotein, albumin, etc. Back up of ECA2870. Almost equal to RCB0459, but the restriction is a. Information  
  RCB1676     JHOM-1     Human ovary mucinous adenocarcinoma cell line. Application consideration  
  RCB1677     JHUEM-7     Human uterus endometrial adenocarcinoma cell line. Application consideration  
  RCB1678     JHOS-4     Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow. Application consideration  
  RCB1680     TUHR25TKB     Human cell line derived from kidney cancer.  
  RCB1682     JHOM-2B     Human ovary mucinous tubular adenocarcinoma cell line. Application consideration  
  RCB1688     JHOC-7     Human ovary clear cell carcinoma cell line. Application consideration  
  RCB1695     RMS-YM     Embryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.  
  RCB1698     LY-B     Serine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.  
  RCB1701     MY     Human cell line derived from p180-BCR-ABL dependent leukemia.  
  RCB1702     SLVL     Human cell line derived from splenic B cell lymphoma.  
  RCB1705     JHCA-ov     Human colon cancer cell line derived from metastasis at ovary. Moderately differentiated adenocarcinoma. Application consideration  
  RCB1706     JHCOLOYI     Human cell line derived from rectal cancer. Application consideration  
  RCB1708     JHTSK-col-L     Human B cell-like cell line derived from colon adenocarcinoma tisuue.  
  RCB1721     JHUCS-3     Human cervical cancer cell line. Application consideration  
  RCB1723     JHOC-8     Human ovary clear cell carcinoma cell line. Application consideration  
  RCB1724     JHSK-rec     Human rectal cancer cell line. Application consideration  
  RCB1728     Hpr-4     H2O2 resistant Chinese Hamster V79 cells  
  RCB1731     TM-31     Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)  
  RCB1741     NHOS     Mouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.  
  RCB1752     BS-SHI-4M     Human cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.  
  RCB1753     KMY-J     Meningioma derived cell line. Derived from rat F344.  
  RCB1754     KMY-1     Subline of KMY-J. Fibroblast-like  
  RCB1755     KMY-2     Subline of KMY-J. Epithelial-like  
  RCB1756     KMY-3     Subline of KMY-J. Polyploidy  
  RCB1757     HS-P     Rat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.  
  RCB1771     Lu-24     Human cell line derived from lung cancer. Oat cell type.  
  RCB1772     Lu-141     Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  
  RCB1773     Lu-143     Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  
  RCB1785     Lu-138     Human cell line derived from lung cancer. Small cell carcinoma. Application consideration  
  RCB1797     BP7(R80)     Rat renal tumor derived cell line.  
  RCB1798     BP11(R2)     Rat (Wistar) cell line derived from renal (kidney) tumor.  
  RCB1799     BP11(R100)     Rat (Wistar) cell line derived from renal (kidney) tumor.  
  RCB1800     BP13(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1801     BP13(R100)     Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  
  RCB1802     BP26(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1803     BP26(R80)     Rat cell line derived from kidney carcinoma. After passage 80. Wistar rat.  
  RCB1804     BP30(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1805     BP30(R100)     Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  
  RCB1806     BP36B(R2)     Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.  
  RCB1807     BP36B(R100)     Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.  
  RCB1829     SC-1     Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.  
  RCB1830     Rat-1     Rat fibroblast-like cell line that can be transformed by oncogenes.  
  RCB1831     XC     Cell line for titration of murine leukemia virus.  
  RCB1832     THK     SV40 transformed hamster cell line. Fibroblast-like cells.  
  RCB1833     Mink     Lung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.  
  RCB1834     S+L-Mink     Mink (RCB1833) cells transformed by Moloney murine sarcoma virus.  
  RCB1835     Sirc     Fibroblast-like cell line derived from rabbit.  
  RCB1846     HSC-F     T cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1847     ES-8040 20-2     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB1848     ES-8047 2-1     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB1849     C-8049     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB1850     C-8052     Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.  
  RCB1854     HSP-239     T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1855     HSP-250     T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1861     T-23     Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB1869     LY-A     Subline of CHO-K1 cell line in which trafficking of ceramide is deficient  
  RCB1871     TL-1     Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607 (Deposited from Tohoku Univ.).  
  RCB1872     A431     Human cell line derivd from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).  
  RCB1873     JTK-LCL     Human B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).  
  RCB1874     KOIA-LCL     EBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).  
  RCB1875     XPL 5     Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309 (Deposited from Tohoku Univ.).  
  RCB1878     RPMI1788     IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).  
  RCB1879     PEER     Human T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).  
  RCB1881     TL-Mor     Human derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.).  
  RCB1882     BALL-1     Human cell line derived from B cell leukemia. TKG0467 (Deposited from Tohoku Univ.).  
  RCB1884     H-111-TC     Human cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.). Cell growth is slow.  
  RCB1886     Hep G2     Human cell line derived from hepatocyte carcinoma. TKG0205 (Deposited from Tohoku Univ.). Information  
  RCB1889     HEp-2     Supports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.).  
  RCB1890     MG-63     Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN. TKG0294 (Deposited from Tohoku Univ.).  
  RCB1891     HeLa TG     A subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).  
  RCB1892     SKG-IIIa     Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).  
  RCB1894     TE-1     Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).  
  RCB1896     TN-2     Human cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).  
  RCB1897     K562     Human cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes. TKG0210 (Deposited from Tohoku Univ.).  
  RCB1898     K562/Adr     Subline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).  
  RCB1900     Lu99     Lung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).  
  RCB1901     PK-59     Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).  
  RCB1902     HSC-4     Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).  
  RCB1903     OVK18     Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).  
  RCB1904     MCF7     Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).  
  RCB1905     Sq-1     Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration  
  RCB1907     TKKK     Human cell line derived from intrahepatic bile duct cancer. TKG0456 (Deposited from Tohoku Univ.).  
  RCB1909     8305C     Human thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).  
  RCB1925     WA-mFib     Mouse stromal cell line for human lung small cell carcinoma cell line, WA-ht. Cell growth is slow.  
  RCB1928     KG-1a     Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.).  
  RCB1932     T2     Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).  
  RCB1933     NALM-6     Human cell line derived from B cell leukemia. TKG0413 (Deposited from Tohoku Univ.).  
  RCB1934     HUT78     Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375 (Deposited from Tohoku Univ.).  
  RCB1935     HPB-ALL     Human cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.).  
  RCB1936     MOLT-4F     Human T leukemic cell line (CD4+). CR2 receptor (+). TKG0229 (Deposited from Tohoku Univ.).  
  RCB1938     P30/OHK     Human cell line derived from T cell leukemia. TKG0463 (Deposited from Tohoku Univ.).  
  RCB1939     NUGC-4     Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).  
  RCB1940     SH-10-TC     Human cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412 (Deposited from Tohoku Univ.).  
  RCB1941     Li-7     Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing. TKG0368 (Deposited from Tohoku Univ.).  
  RCB1942     HuH-7     Human cell line derived from hepatoma. TKG0206 (Deposited from Tohoku Univ.).  
  RCB1943     HuH-28     Human cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.).  
  RCB1945     HSC-2     Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).  
  RCB1947     Ca Ski     Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).  
  RCB1949     TE-5     Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).  
  RCB1950     TE-6     Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257 (Deposited from Tohoku Univ.).  
  RCB1951     TE-15     Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).  
  RCB1952     SCCH-26     Human neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).  
  RCB1953     NB-1     Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486 (Deposited from Tohoku Univ.).  
  RCB1954     T98G     Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471 (Deposited from Tohoku Univ.).  
  RCB1955     KMST-6     Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic. TKG0482 (Deposited from Tohoku Univ.).  
  RCB1960     HuCCT1     Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389 (Deposited from Tohoku Univ.).  
  RCB1963     VMRC-RCW     Human renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).  
  RCB1965     EBC-1     Human lung squamous cell carcinoma cell line. TKG0481 (Deposited from Tohoku Univ.).  
  RCB1966     S1     Human cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration  
  RCB1967     LU65     Human lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).  
  RCB1970     LK-2     Human lung squamous cell carcinoma cell line. TKG0494 (Deposited from Tohoku Univ.).  
  RCB1971     Lu99B     Human lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).  
  RCB1972     PK-1     Human pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239 (Deposited from Tohoku Univ.).  
  RCB1973     PK-45H     Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).  
  RCB1974     SAS     Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).  
  RCB1975     HSC-3     Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).  
  RCB1976     Ca9-22     Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485 (Deposited from Tohoku Univ.).  
  RCB1980     CCRF-CEM     Human cell line derived from T cell leukemia. TKG0563 (Deposited from Tohoku Univ.).  
  RCB1981     HD-Mar2     Human cell line derived from Hodgkin's lymphoma. TKG0198 (Deposited from Tohoku Univ.).  
  RCB1988     TE-9     Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).  
  RCB1992     UV♂1d     Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.  
  RCB1993     UV♀1A     Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.  
  RCB1994     UV♀2     Mouse vascular endothelial cell line. Transformed by ultraviolet.  
  RCB1995     UV·BAL-1.1     Mouse skin derived cell line. Induced by ultra-violet irradiation.  
  RCB1996     UV·BAL-2.1D     Mouse skin derived cell line. Induced by ultra-violet irradiation.  
  RCB1997     UV·B6-1.1     Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.  
  RCB1998     UV·B6-2.1A     Mouse skin derived cell line. Induced by ultra-violet irradiation.  
  RCB1999     UV·B6-4.1     Mouse fibroblast-like cell line derived from skin. C57BL/6 strain.Induced by ultra-violet irradiation.  
  RCB2000     UV·B6-5.1     Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.  
  RCB2024     UV·BAL-3.3     Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Neuron-like)  
  RCB2025     UV·BAL-5.4G     Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Epithelial-like)  
  RCB2026     UV·BAL-6.1E     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2027     UV·BAL-7.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2028     UV·BAL-8.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2029     UV·BAL-8.1C     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2030     UV·BAL-12.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2031     UV·BAL-13.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2032     UV·BAL-14.2     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2033     UV·BAL-15.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2034     UV·BAL-16.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2035     UV·BAL-17.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2036     UV·BAL-18.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2053     UV·C3H-3.3     Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.  
  RCB2056     UV·C3H-8.2     Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.  
  RCB2057     UV·BAL-19.1A     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2058     UV·BAL-20.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2059     UV·BAL-21.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2060     UV·BAL-23.1     Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.  
  RCB2061     UV·C3B6-1.1     Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2062     UV·C3B6-1.1C     Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2065     UV•CB6-2.1F     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2066     UV·CB6-3.4B     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2067     UV•CB6-4.1D     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2068     UV•CB6-4.1F     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2070     UV·CB6-5.2     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2071     UV·CB6-5.2B     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2072     UV•CB6-6.1     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2073     UV•CB6-6.1B     Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.  
  RCB2074     UV·CC3-11.1     Mouse fibroblast-like cell line derived from skin. (BALB/cxC3H)F1 strain. Induced by ultra-violet irradiation.  
  RCB2076     Has     Chinese hamster cell line. Epithelial-like adherent cells.  
  RCB2078     FU-RPNT-2     Human primitive neuroectodermal tumor cell line derived from kidney.  
  RCB2082     103-LCL     Human B cell line transformed by Epstein-Barr Virus. TKG0614 (Deposited from Tohoku Univ.).  
  RCB2083     141-LCL     Human B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient. TKG0611 (Deposited from Tohoku Univ.).  
  RCB2084     TALL-1     Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).  
  RCB2088     Kato III     Human cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).  
  RCB2092     87-5     Human cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).  
  RCB2093     II-18     Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).  
  RCB2094     MIA Paca2     Human cell line derived from pancreatic cancer. TKG0227 (Deposited from Tohoku Univ.).  
  RCB2095     PANC-1     Human cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).  
  RCB2097     TE-4     Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0255 (Deposited from Tohoku Univ.).  
  RCB2098     TE-8     Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259 (Deposited from Tohoku Univ.).  
  RCB2099     TE-10     Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261 (Deposited from Tohoku Univ.).  
  RCB2100     TE-11     Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262 (Deposited from Tohoku Univ.).  
  RCB2101     TE-14     Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265 (Deposited from Tohoku Univ.).  
  RCB2102     HO-1-u-1     Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).  
  RCB2103     8505C     Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma. TKG0439 (Deposited from Tohoku Univ.).  
  RCB2104     HuO-3N1     Human cell line derived from osteosarcoma. TKG0452 (Deposited from Tohoku Univ.).  
  RCB2105     D98-AH2     Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191 (Deposited from Tohoku Univ.).  
  RCB2106     ME-180     Human cell line derived from cervical cancer. TKG0437 (Deposited from Tohoku Univ.).  
  RCB2107     TN-1     Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).  
  RCB2108     NH-12     Human cell line derived from neuroblastoma. TKG0448 (Deposited from Tohoku Univ.).  
  RCB2109     NH-6     Human cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).  
  RCB2110     YKG1     Human cell line derived from glioblastoma. TKG0453 (Deposited from Tohoku Univ.).  
  RCB2111     K562/Vin     Subline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).  
  RCB2127     COLO205     Human cell line derived from colon cancer. Derived from ascites metastasis. Cell growth is slow. TKG0457 (Deposited from Tohoku Univ.).  
  RCB2128     A-THP-1     Human cell line derived from acute monocytic leukemia. Activeated macrophage activity (+), obtained from long passage of THP-1 (RCB1189 THP-1) cell line. TKG0296 (Deposited from Tohoku Univ.).  
  RCB2133     S2     Human cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration  
  RCB2134     86-2     Human cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).  
  RCB2135     NIH:OVCAR-3     Human cell line derived from adenocarcinoma of ovary. TKG0602 (Deposited from Tohoku Univ.).  
  RCB2136     YST-1     Human cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).  
  RCB2138     KLM-1     Human cell line derived from pancreatic cancer. RCB1972 was derived from the same patient. TKG0490 (Deposited from Tohoku Univ.).  
  RCB2141     PK-45P     Human cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient. TKG0493 (Deposited from Tohoku Univ.).  
  RCB2143     DU145     Human cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).  
  RCB2144     LNCap.FGC     Human cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis. TKG0603 (Deposited from Tohoku Univ.).  
  RCB2145     PC-3     Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).  
  RCB2146     WERI-Rb-1     Human cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).  
  RCB2202     293T     Human cell line expressing SV40 large T antigen abundantly.  
  RCB2205     NCC-RbC-39     Human retinoblastoma cell line.  
  RCB2206     NCC-RbC-51     Human retinoblastoma cell line derived from cervical lymph node metastasis.  
  RCB2208     NCC-RbC-54     Human cell line derived from retinoblastoma.  
  RCB2212     NCC-RbC-59     Human cell line derived from retinoblastoma. Cell growth is slow.  
  RCB2213     NCC-RbC-60     Human cell line derived from retinoblastoma.  
  RCB2214     NCC-RbC-67     Human cell line derived from retinoblastoma.  
  RCB2217     NCC-RbC-83     Human cell line derived from retinoblastoma.  
  RCB2218     NCC-RbC-92     Human cell line derived from retinoblastoma.  
  RCB2219     NCC-RbC-T1     Human cell line derived from retinoblastoma.  
  RCB2223     NCC-OvC-K119     Human cell line derived from ovarian cancer.  
  RCB2224     NCC-StC-K140     Human cell line derived from stomach cancer.  
  RCB2225     JHUEM-14     Human cell line derived from uterus cancer. Endometrioid adenocarcinoma. Application consideration  
  RCB2226     JHOC-9     Human cell line derived from ovary cancer. Clear cell carcinoma. Application consideration  
  RCB2227     JMSU1     Human cell line derived from urinary bladder carcinoma. Derived from ascites.  
  RCB2229     HS-Os-1     Human cell line derived from osteosarcoma.  
  RCB2230     HS-Sch-2     Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).  
  RCB2231     HS-SY-II     Human cell line derived from synovial sarcoma. Application consideration  
  RCB2277     GSS     Human gastric cancer cell line derived from metastasis at liver.  
  RCB2278     GSU     Human cell line derived from gastric cancer. Established from the cells in ascites.  
  RCB2279     WA-hT     Human cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.  
  RCB2281     T3M-12     Human lung small cell carcinoma cell line. ADH producing.  
  RCB2282     701-LCL     Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610 (Deposited from Tohoku Univ.).  
  RCB2283     277-LCL     Human B cells transformed by Epstein-Barr virus. TKG0609 (Deposited from Tohoku Univ.).  
  RCB2286     XPL 17     Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311 (Deposited from Tohoku Univ.).  
  RCB2287     XPL 20     Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313 (Deposited from Tohoku Univ.).  
  RCB2288     211-LCL     Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616 (Deposited from Tohoku Univ.).  
  RCB2292     ACC-MESO-1     Human malignant pleural mesothelioma cell line.  
  RCB2293     ACC-MESO-4     Human malignant pleural mesothelioma cell line.  
  RCB2299     RMC-1     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2300     RMC-2     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2301     RMC-3     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2302     RMC-6     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2303     RMC-11     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2304     RMC-17     Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.  
  RCB2318     P19.CL6     Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.  
  RCB2319     LACF-NaNaI     Fibroblast-like cells derived from African Savannah Elephant (http://www.bioone.org/doi/full/10.3106/041.034.0307). Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2320     LACF-NaNaII     Fibroblast-like cells derived from African Savannah Elephant (http://www.bioone.org/doi/full/10.3106/041.034.0307). Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).  
  RCB2326     CHO-AA8     A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.  
  RCB2327     EM-9     A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.  
  RCB2328     irs1SF     A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.  
  RCB2329     V-3     A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.  
  RCB2330     CHO-K1     Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.  
  RCB2331     XR-1     A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.  
  RCB2332     V79-4     A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.  
  RCB2335     V-E5     X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.  
  RCB2336     V-G8     A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.  
  RCB2337     V79B     A subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.  
  RCB2338     XR-V9B-4     A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.  
  RCB2339     XR-V15B     A subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.  
  RCB2341     NCR-G1     Human cell line derived from embryonal carcinoma of testis.  
  RCB2342     NCR-G2     Human cell line derived from embryonal carcinoma of testis.  
  RCB2343     NCR-G3     Human cell line derived from embryonal carcinoma of testis.Application consideration  
  RCB2344     NCR-G4     Human cell line derived from embryonal carcinoma of testis.  
  RCB2345     EEB     Human cell line derived from erythroblastic leukemia.  
  RCB2346     NMFH-1     Human cell line derived from myxofibrosarcoma.  
  RCB2347     NMS-2     Human cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2348     NOS-10     Human cell line derived from osteosarcoma.  
  RCB2351     OGU1     Human cell line derived from primary effusion lymphoma (PEL). Application consideration  
  RCB2352     633     Human lung cancer cell line expressing capsid protein of human adenovirus.  
  RCB2354     293gp     Retroviral vector packaging cell line expressing MoMLV (Moloney murine leukemia virus) gag/pol. Production of high titer retrovirus by cotransfection of envelope and vector plasmids.  
  RCB2355     HeLa CD4+Clone1022     A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.  
  RCB2356     HeLa-CD4-LTR-β-gal     A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.  
  RCB2358     HLtat     A subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.  
  RCB2360     HS-ES-2M     Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.  
  RCB2361     HS-ES-2R     Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.  
  RCB2362     HS-PSS     Human cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2364     HS-ES-1     Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-2M, 2R cell lines.  
  RCB2365     JHONA     Human cell line derived from ovarian squamous cell cancer. Application consideration  
  RCB2403     MG6     Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.  
  RCB2530     A172     Human cell line derived from glioblastoma. TKG0183 (Deposited from Tohoku Univ.).  
  RCB2531     CB-3512     Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305 (Deposited from Tohoku Univ.).  
  RCB2532     HuO 9N2 (O9N2)     Human cell line derived from osteosarcoma. TKG0451 (Deposited from Tohoku Univ.).  
  RCB2534     M-MOK     Human cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).  
  RCB2535     OVK18#102     Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357 (Deposited from Tohoku Univ.).  
  RCB2536     T24     Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).  
  RCB2537     TFK-1     Human cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).  
  RCB2539     XPL 19     Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312 (Deposited from Tohoku Univ.).  
  RCB2540     XPL 24     Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314 (Deposited from Tohoku Univ.).  
  RCB2541     141-LCL-MUC1     Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).  
  RCB2610     FELV3281-AD     Cat cell line derived from lymphoma.  
  RCB2611     MDCK-AD     Dog cell line derived from kidney.  
  RCB2614     KLN205-MUC1     Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).  
  RCB2618     BCL1-B20     Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).  
  RCB2619     L929     Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).  
  RCB2620     C-1300N18     Mouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.). Application consideration  
  RCB2621     M1(D+)     Mouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).  
  RCB2623     KLN205     Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).  
  RCB2627     BOY-12E     Human cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).  
  RCB2630     B16 F10     Mouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).  
  RCB2633     MM46 CEA1-2     Mouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).  
  RCB2634     MM46-APR-MUC1 cl.1     Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).  
  RCB2637     A4     Subline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).  
  RCB2638     B16/BL6     Mouse cell line derived from melanoma.  TKG0598 (Deposited from Tohoku Univ.).  
  RCB2639     NB2a     Mouse cell line derived from neuroblastoma. TKG0509 (Deposited from Tohoku Univ.).  
  RCB2640     G-415     Human cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).  
  RCB2642     MUSS     Mouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497 (Deposited from Tohoku Univ.).  
  RCB2643     F9     Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration  
  RCB2648     D4     A subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). Cell growth is slow. TKG0300 (Deposited from Tohoku Univ.).  
  RCB2649     B16 F1     Mouse cell line derived from melanoma. C57BL/6J strain. TKG0347 (Deposited from Tohoku Univ.).  
  RCB2651     JLS-V9     Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).  
  RCB2652     J774-1     Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).  
  RCB2657     Colon-26     Mouse cell line derived from rectal cancer. BALB/c strain. TKG0518 (Deposited from Tohoku Univ.).  
  RCB2660     MEDEP-E14     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.  
  RCB2686     JTC-35     Bovine granulosa cell line.  
  RCB2691     MEDEP-E14 clone 4     A subclone of MEDEP-E14(RCB2660) following cloning procedure.  
  RCB2692     MEDEP-BRC4-1     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.  
  RCB2693     MEDMC-NT2     Mouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.  
  RCB2694     MEDMC-BRC6     Mouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.  
  RCB2700     PK-8     Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).  
  RCB2710     Atg5^(+/+)MEF     Mouse embryonic fibroblasts. Wild type control for RCB2711.  
  RCB2711     Atg5^(-/-)MEF     Mouse embryonic fibroblasts lacking Atg5 gene expression.  
  RCB2712     MAEC     Mouse cell line derived from aorta of p53-deficient mouse. Epithelial like.  
  RCB2718     MT-7     Rat cell line derived from fibrous histiocytoma. After cloning.  
  RCB2719     MT-10     Rat cell line derived from fibrous histiocytoma. After cloning.  
  RCB2720     MT-R8     A subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  
  RCB2721     MT-R9     A subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  
  RCB2722     MT-10R     A subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.  
  RCB2723     MT-PR     A subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. The parent cell line, MT-P, is also deposited but not available yet.  
  RCB2724     KB-D8     Rat cell line derived from dendritic cell carcinoma in thymus.  
  RCB2725     KJ-A     Rat cell line derived from malignant fibrous histiocytoma.  
  RCB2726     KE-F11     Rat cell line derived from malignant schwannoma.  
  RCB2727     RY-B-E3     Rat cell line derived from endometrial stromal sarcoma.  
  RCB2728     LY-H12     Rat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2729     LY-PPB6     Rat cell line derived from malignant peripheral nerve sheath tumor.  
  RCB2745     A20     Mouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).  
  RCB2758     LAG     Mouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).  
  RCB2766     Morris 5123D-TC     Rat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).  
  RCB2776     P388     Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.).  
  RCB2782     RBL 2H3     Rat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).  
  RCB2783     RGC-6     Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).  
  RCB2784     RL♂1(Gloria)     Mouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).  
  RCB2799     YAC-1     Mouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).  
  RCB2806     MSK-C5.8G     Rat cell line derived from osteosarcoma. F344 strain.  
  RCB2808     Odf2-deficient F9 cells     A subline of mouse ES cell line, F9 (129), lacking Odf2.  
  RCB2809     CH12F3-2A     Mouse cell line derived from B cell lymphoma.  
  RCB2812     HeLa/Fucci     A subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4. Important notice regarding nomenclature of Fucci.  
  RCB2813     NMuMG/Fucci     A subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci.  
  RCB2814     COS/Fucci     Subline of COS cell line expressing Fucci, a marker of cell cycle. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES). Important notice regarding nomenclature of Fucci.  
  RCB2816     A110L     Human cell line derived from lung adenocarcinoma cells.  
  RCB2817     A529L     Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.  
  RCB2818     B1203L     Human cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.  
  RCB2819     C831L     Human cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.  
  RCB2830     OMC-2     Human cell line derived from endometrial adenocarcinoma. Cell growth is slow.  
  RCB2831     DEOC-1     Human cell line derived from malignant melanoma. Cell growth is slow.  
  RCB2832     OMC-9     Human cell line derived from endometrial stromal sarcoma.  
  RCB2844     L1210 TGR4     Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478 (Deposited from Tohoku Univ.).  
  RCB2846     LAG-MUC1     A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).  
  RCB2848     OTT6050(B)     Mouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330 (Deposited from Tohoku Univ.).  
  RCB2852     TSA8     Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370 (Deposited from Tohoku Univ.).  
  RCB2853     WEHI-3B     Mouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).  
  RCB2854     C6     Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).  
  RCB2859     K-251     Rat cell line derived from hepatoma cells in ascites. TKG0130 (Deposited from Tohoku Univ.).  
  RCB2860     MRMT-1     Rat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.).  
  RCB2862     SLC     Rat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).  
  RCB2863     N14.5     Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus  
  RCB2864     OLP6     Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus  
  RCB2867     HeLa/Fucci2     A subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci.  
  RCB2868     NMuMG/Fucci2     A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5.Important notice regarding nomenclature of Fucci.  
  RCB2869     CHO-K1     A subline of CHO cells. Require proline. TKG0328 (Deposited from Tohoku Univ.).  
  RCB2896     JLS-V9 6TG     Mouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350 (Deposited from Tohoku Univ.).  
  RCB2899     S180-Kumamoto-TC     Mouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).  
  RCB2900     S180-Meiji-TC     Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).  
  RCB2901     S180-NCC-TC     Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).  
  RCB2904     WEHI164R     Mouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).  
  RCB2905     WEHI164S     Mouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).  
  RCB2908     AH272-TC     Rat cell line derived from hepatoma cells in ascites. TKG0535 (Deposited from Tohoku Univ.).  
  RCB2909     Walker256-TC     Rat cell line derived from mammary carcinoma. TKG0565 (Deposited from Tohoku Univ.).  
  RCB2910     LY-6-TC     Rat cell line derived from sarcoma cells in ascites. TKG0648 (Deposited from Tohoku Univ.).  
  RCB2911     MEDEP-BRC5     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.  
  RCB2932     MEDEP-BRC4-2     Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.  
  RCB2979     HCT116     Human cell line derived from colon cancer. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2980     HCT116-XRCC4(+/-)     Subline of HCT116 cell line lacking XRCC4 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2981     HCT116-XRCC4(-/-)     Subline of HCT116 cell line lacking XRCC4 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2982     HCT116-RAD18(+/-)     Subline of HCT116 cell line lacking RAD18 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2983     HCT116-RAD18(-/-)     Subline of HCT116 cell line lacking RAD18 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2984     HCT116-ARTEMIS(+/-)     Subline of HCT116 cell line lacking ARTEMIS gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2985     HCT116-ARTEMIS(-/-)     Subline of HCT116 cell line lacking ARTEMIS gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2986     HCT116-MDC1(+/-)     Subline of HCT116 cell line lacking MDC1 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2987     HCT116-MDC1(-/-)     Subline of HCT116 cell line lacking MDC1 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2988     HCT116-REV1(+/-)     Subline of HCT116 cell line lacking REV1 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2989     HCT116-REV1(-/-)     Subline of HCT116 cell line lacking REV1 gene in both alleles. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2990     HCT116-REV3L(+/-)     Subline of HCT116 cell line lacking REV3L gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2991     HCT116-KU70(+/-)     Subline of HCT116 cell line lacking Ku70 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2992     HCT116-DNAPKcs(+/-)     Subline of HCT116 cell line lacking DNAPKcs gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2993     HCT116-POLM(+/-)     Subline of HCT116 cell line lacking DNA polymerase m gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2994     HCT116-LIG3(+/-)     Subline of HCT116 cell line lacking Ligase 3 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2995     HCT116-LIG4(+/-)     Subline of HCT116 cell line lacking Ligase 4 gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2996     HCT116-53BP1(+/-)     Subline of HCT116 cell line lacking 53BPI gene in one allele. Loss of the DNA mismatch repair gene (hMLH1).  
  RCB2997     H414     Subline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).  
  RCB2998     H414-RAD18(+/-)     Subline of H414 cell line lacking RAD18 gene in one allele.  
  RCB2999     H414-RAD18(-/-)     Subline of H414 cell line lacking RAD18 gene in both alleles.  
  RCB3000     H414-MDC1(+/-)     Subline of H414 cell line lacking MDC1 gene in one allele.  
  RCB3001     H414-MDC1(-/-)     Subline of H414 cell line lacking MDC1 gene in both alleles.  
  RCB3002     H414-LIG4(+/-)     Subline of H414 cell line lacking Ligase 4 gene in one allele.  
  RCB3007     MOPC-70A     Mouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).  
  RCB3008     NC37     HGPRT(-), resistant to ouabain, partner cells for human B hybridoma. Ig nonproducer, human B lymphoblastoid cell line. This line and Raji(TKG0371)are derived from the same individual. TKG0232 (Deposited from Tohoku Univ.).  
  RCB3010     RPMI8226     Human cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.).  
  RCB3052     Jurkat     Human T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).  
  RCB3515     JLS-V9 BudR     Mouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356 (Deposited from Tohoku Univ.).  
  RCB3530     B901L     Human cell line derived from lung adenocarcinoma cells.  
  RCB3531     A904L     Human cell line derived from lung large cell carcinoma cells.  
  RCB3532     A129L     Human cell line derived from lung adenocarcinoma cells.  
  RCB3576     Aska-SS     Human cell line derived from synovial sarcoma.  
  RCB3577     Yamato-SS     Human cell line derived from synovial sarcoma.  
  RCB3586     hPSC-1     Human cell line derived from choronic pancreatitis. Pancreatic stellate cells.  
  RCB3588     hPSC-5     Human cell line derived from pacreatic cancer. Pancreatic stellate cells.  
  RCB3589     hPSC-14     Human cell line derived from pacreatic cancer. Pancreatic stellate cells.  
  RCB3600     SDR-P-1D5     Rat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.  
  RCB3601     SDRL-1     Rat cell line derived from liver lacking growth hormone.  
  RCB3602     SDRL-2     Rat cell line derived from liver lacking growth hormone.  
  RCB3673     Raji     Human cell line derived from Burkitt lymphoma. EBNA (EBV―nuclear antigen) positive. TKG0371 (Deposited from Tohoku Univ.).  
  RCB3675     SCC-TC     Rectal carcinoma. Culture cell line of SCC (TKG 0340) . TKG0646 (Deposited from Tohoku Univ.).  
  RCB3676     5637     Human cell line derived from bladder carcinoma. TKG0605 (Deposited from Tohoku Univ.).  
  RCB3677     A549     Human cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184 (Deposited from Tohoku Univ.).  
  RCB3678     BeWo     Human cell line derived from choriocarcinoma. TKG0567 (Deposited from Tohoku Univ.).  
  RCB3680     HeLa     Human cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).  
  RCB3681     HeLa.P3(S)     Subline of HeLa cell line. Serum-free culture is possible. TKG0465 (Deposited from Tohoku Univ.).  
  RCB3682     HeLa S3     Human cell line derived from cervical cancer. TKG0444 (Deposited from Tohoku Univ.).  
  RCB3685     HMV-II     Human cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).  
  RCB3686     THP-1     Human cell line derived from monocytic leukemia. TKG0267 (Deposited from Tohoku Univ.).  
  RCB3687     MKN-7     Human cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma). TKG0228 (Deposited from Tohoku Univ.).  
  RCB3688     Saos-2     Human cell line derived from osteogenic sarcoma cells. TKG0469 (Deposited from Tohoku Univ.).  
  RCB3706     Atg7 +/+ MEFs     Mouse embryonic fibroblasts derived from wild type mouse (C57BL/6).  
  RCB3707     Atg7 -/- MEFs     Mouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).  
  RCB3708     Atg3 +/+ MEFs     Mouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.  
  RCB3709     Atg3 -/- MEFs     Mouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.  
  RCB4451     UPS-1     Sub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).  
  RCB4452     FL-YB     Mouse follicular dendritic cell line  
  RCB4455     PC-9     Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)   
  RCB4472     IN-IC     Rat cell line derived from kidney.  
  RCB4474     Ba/F3-CL1     Mouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3). Information  
  RCB4476     Ba/F3     Mouse pro-B cell line derived from C3H strain. IL-3 dependent. Information  
  RCB4498     NP 2     Human cell line derived from anaplastic glioma.  
  RCB4499     Onda 10     Human cell line derived from anaplastic glioma.  
  RCB4500     Onda 11     Human cell line derived from glioblastoma.  
  RCB4504     NP 3     Human cell line derived from anaplastic glioma.  
  RCB4505     NP 5     Human cell line derived from anaplastic glioma.  
  RCB4519     Orai2^(-/-)DT40     A subline of avian cell line, DT40, lacking Orai2 gene.  
  RCB4548     PT-r     Rat cell line derived from parathyroid gland.  
  RCB4561     MOLT-17     Human cell line derived from T cell leukemia (T-ALL). ACC 36 (Deposited from DMSZ.).  
  RCB4592     r/mHM-SFME-1     Comment.  
  RCB4593     CALM WT MEF     CALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.      
  RCB4594     CALM KO MEF     CALM deficient MEF cells. Tranformed with SV40 large T antigen gene.  
  RCB4623     Ba/ER     Ba/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.  
  RCB4627     KUP5     An immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 adult mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution).  
  RCB4662     HCT116 CMV-OsTIR1     This is an HCT116 cell line in which CMV-OsTIR1 (pMK232, PURO) was introduced at the both alleles of the AAVS1 locus by using CRISPR/Cas.This parental cell line consitutively express OsTIR1 and can be used for generation of AID mutants.  
  RCB4680     MS-5     Mouse stromal cell line which supports hematopoietic cells.  
  RCB4681     MS-K     Murine cell line derived from sarcoma.  
back back
RIKEN BioResource Center